CRANBURY, N.J. & SHANGHAI - Thursday, 23. February 2023 AETOSWire Print
(BUSINESS WIRE)--Accutar Biotechnology, Inc., a clinical stage biotechnology company focusing on artificial intelligence (AI)-empowered drug discovery, announces the dosing of the first patient in China in a Phase 1 study o…